Adjunctive therapy delivery using a dbs lead
AssigneeBoston Scientific Neuromodulation Corporation
InventorsBarbara Huibregtse, Anne M. Pianca, Eric Schneider, Lynne Swanson
Life of this patent
Estimating the term…
Abstract
Various aspects of the present disclosure are directed toward apparatuses, systems and methods for treating an ischemic brain injury. Certain aspects include delivering the treatment substrate to a therapy region in a patient's brain. In addition, certain aspects of the disclosure can include using a number of electrodes arranged with a deep brain stimulation lead to identify the therapy region.
Claims20
A deep brain stimulation lead, the lead comprising:
- a lead body;
- a plurality of electrodes arranged on the lead body, wherein at least one of the plurality of electrodes is configured to obtain a physiological signal indicative of a therapy region;
- and
- a lumen arranged within the lead body and configured to facilitate delivery of a treatment substrate to the therapy region.
A deep brain stimulation system, comprising:
- a lead comprising:
- a lead body;
- a plurality of electrodes arranged circumferentially around the lead body, wherein at least one of the plurality of electrodes is configured to obtain a physiological signal;
- and
- a lumen arranged within the lead body and configured to facilitate delivery of a treatment substrate to a therapy region;
- and
- a controller communicatively coupled to the lead, the controller configured to:
- receive the physiological signal;
- and
- identify the therapy region based on the physiological signal.
A method for treating a brain condition of a patient using a treatment substrate, the method comprising:
- identifying, using a lead having a plurality of electrodes arranged thereon, a therapy region based on a physiological signal obtained by at least one of the plurality of electrodes;
- and
- delivering, via a lumen arranged within the lead, the treatment substrate to the therapy region.
Dependencies are inferred from the claim text.